← Eichor
Condition: No Reflow Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: No Reflow

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track
NA · 1 location(s) · Kafrelsheikh University · NCT06966674
Risk Factors for Microvascular Obstruction Post-Emergency PCI in AMI Patients
Phase N/A · 1 location(s) · The Third Xiangya Hospital of Central South University · NCT07042321
Investigation of Brain Blood Flow Changes in Acute Ischemic Stroke Patients After Successful Endovascular Thrombectomy
Phase N/A · 1 location(s) · University of Zurich · NCT07534319
Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention
Phase 4 · 2 location(s) · National Institute of Cardiovascular Diseases, Pakistan · NCT07536802
Image Detection of Impaired Microcirculatory Reperfusion
Phase N/A · 1 location(s) · University of Cincinnati · NCT07099599
A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT ReductioN of DecREased TI
Phase 4 · 1 location(s) · Korea University Anam Hospital · NCT05427786
The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow
Phase 3 · 1 location(s) · Ain Shams University · NCT06847568
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent
Phase 2/Phase 3 · 12 location(s) · University of Melbourne · NCT05892510
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.